STAR Trial (Siegel Transcatheter Aortic Valve Replacement in Patients With Symptomatic Severe Aortic Stenosis)

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 1025 participants.

Also called NCT07278310

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 1,025 participants (planned count) (from the registry)
Sponsor
MiRus (from the registry)
Registry
  • NCT NCT07278310
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07278310. Randomized; single masking; primary purpose treatment. Start 2026-04 (anticipated); primary completion 2028-04 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
STAR Trial (Siegel Transcatheter Aortic Valve Replacement in Patients With Symptomatic Severe Aortic Stenosis)
Condition
Symptomatic Severe Native Aortic Stenosis
Condition
Aortic Stenosis
Intervention (Device)
TAVR Device
Intervention (Device)
Siegel TAVR Device
Lead sponsor
MiRus (class: industry)

Record details

Record id
cardio:ct-nct07278310
Content hash
008a73fa459db3275bfab0bccc049178a5f44e9e213b164f68071bfb431a4da7